Exosens Reports Robust FY 2024 Financial Results, Surpasses IPO Targets

Exosens, a high-tech company in the amplification and imaging sector, announced a substantial revenue increase of 35% in 2024, reaching €394.1 million. The rise, which surpassed IPO estimates, was fueled by significant like-for-like growth and acquisitions. Profit margins also improved, with adjusted EBITDA growing by 37.8% to €118.5 million, achieving a margin of 30.1%. Net profit saw a significant increase, reaching €30.7 million, a 66.7% growth over the previous year.

Looking forward to 2025, Exosens anticipates revenue growth in the high-teens range and plans to expand its production capacity. The company announced a proposed dividend of €0.10 per share for FY 2024, its first since going public. Ongoing strong demand in global defense markets, particularly from NATO countries, is expected to continue driving growth, supported by planned investments in Europe and a new production facility in the United States.